AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
65 hedge funds and large institutions have $57.6M invested in AVEO Pharmaceuticals, Inc. in 2020 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+30
Holders Change %
+85.71%
% of All Funds
1.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
35
Increased
16
Reduced
5
Closed
5
Calls
$8.43M
Puts
$5.65M
Net Calls
+$2.78M
Net Calls Change
+$2.27M
Top Buyers
| 1 |
NMC
1
NEA Management Company
Timonium,
Maryland
|
$20.4M |
| 2 |
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
|
$6.95M |
| 3 |
3
BlackRock
New York
|
$4.49M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$5.58M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$2.06M |
